21 November 2017
News and Views
Links and Services
This week's issue of Lancet investigates the issue of adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy.
D2 gastrectomy is recommended in US and European guidelines, and is preferred in east Asia, for p
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors